Learn how governed AI and Agile workflows help regulatory teams scale plain language summaries for CTIS, reduce manual rework, and support clearer, more consistent outputs—featuring a live AgileWriter.ai® demo.
This webinar explores a practical operating model for scaling PLS development using governed AI and Agile-informed workflows where AI agents orchestrate drafting, review, and revision tasks within defined governance controls. Attendees will learn how structured templates, source anchored drafting, readability targets, and human-in-the-loop quality control can be combined to reduce manual effort (reduce cycle times and rework) while maintaining clarity, traceability, and regulatory confidence. The session concludes with a live AgileWriter® demonstration showing how AI-enabled workflows facilitate iterative drafting, review, and localization of PLS content aligned with CTIS timelines and provide a scalable blueprint for modernizing PLS operations in an increasingly transparent regulatory environment.
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].





Chief Innovation Officer, Synterex Inc.
Jason Casavant is the chief innovation officer at Synterex, Inc. Over his 25+ years of experience in the life sciences and clinical research industry, Jason has brought a passion for innovation and technology to his leadership of medical writing, GCP quality assurance, operations, and training teams. This breadth of expertise reflects a strong foundation in both technical and leadership domains, allowing him to drive compliance and operational excellence across complex projects. In addition to technical expertise, he has contributed thought leadership through presentations and discussions on topics such as motivation, engagement, and agile methodologies in regulated environments, emphasizing continuous improvement and adaptive project management practices.
CEO, Synterex Inc.
Jeanette Towles is the Founder and CEO of Synterex, Inc., a hybrid micro-SaaS and consulting firm pioneering the digital transformation of regulatory science by connecting data, content, and compliance across the drug development lifecycle. Synterex is the home of AgileWriter.ai®, an AI-enabled authoring platform that gets your important information to the intended audience, be it plain language or technical content. Recognized for its EcoVadis sustainability certification, Synterex integrates responsible automation, accessibility, and ethical AI into every layer of its design. Jeanette champions a vision of democratized AI in healthcare—where technology accelerates discovery, enhances transparency, and expands equitable access to innovation. Prior to starting the company, she held in-house consulting and FTE medical writing and clinical science positions at both small- and large-size companies, including managing a group of programmers and vendors working on automated documents, with cumulative industry experience of nearly 20 years.

Medical Writing Associate, Synterex Inc.
Elizabeth Patterson is a medical writing associate with a background in nonclinical oncology research. She spent her first years at Synterex on the operations team where she gained valuable customer-facing experience across the business, sales, and marketing sectors. In her current role, Elizabeth applies her integrated experience to support the backend development of AgileWriter.
Associate Director of AI and Automation R&D, Synterex Inc.
Sahishnu Patel, Ph.D., is the associate director of AI and automation R&D at Synterex, where he contributes to identifying emerging innovative platforms and advancing responsible AI practices. Before joining Synterex, Sahishnu spent several years at Amgen as a regulatory and medical writing leader, managing global submission strategy across oncology programs and authoring key submission and publication documents. Earlier in his career, he worked across medical devices and biotech, and supported start-up innovation through the NSF I-Corps program for the NanoScript platform he developed during his doctoral research.We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.